insights_auto
Why is ANVS up 7.29%?
Dive Deeperchevron_right
ANVS:NYSE
Annovis Bio Inc
$1.03
arrow_upward
+7.29%(+0.070) 1D
Oct 20, 10:37:16 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ANVS...
Open
$0.96
High
$1.03
Low
$0.96
Mkt. cap
43.96M
Avg. vol.
956.55K
Volume
141.67K
52-wk high
$5.50
52-wk low
$0.95
EPS
-$1.78
Beta
1.23
Shares outstanding
42.68M
No. of employees
8
Open
$0.96
High
$1.03
Low
$0.96
Mkt. cap
43.96M
Avg. vol.
956.55K
Volume
141.67K
52-wk high
$5.50
52-wk low
$0.95
EPS
-$1.78
Beta
1.23
Shares outstanding
42.68M
No. of employees
8
News stories
From web sources and news partners
Stock Titan
·
4 hours ago
A proxy typo correction puts total 2025 Ernst & Young fees at $515,000 for Annovis Bio (ANVS).
https://www.dars.gov.et/
·
1 month ago
ANVS Q2 2026 Earnings: Narrower-Than-Expected Loss as Clinical-Stage Company Reports No Revenue - Analyst Coverage Count
https://www.dars.gov.et/
·
2 months ago
Annovis Bio (ANVS) Edges Lower But Holds Above Key Support at $1.78 - TPO Profile
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Websiteannovisbio.com